Company profile for Glycotope

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Glycotope Biotechnology offers GMP-compliant biotechnological contract manufacturing based on animal cell culture systems and perfusion fermentation technologies. These services are supported by research and development in immunology, cell biology, molecular biology and protein chemistry. Based on the GlycoExpress technology of Glycotope GmbH, Berlin, we can offer the development and production of pharmaceutical proteins and a...
Glycotope Biotechnology offers GMP-compliant biotechnological contract manufacturing based on animal cell culture systems and perfusion fermentation technologies. These services are supported by research and development in immunology, cell biology, molecular biology and protein chemistry. Based on the GlycoExpress technology of Glycotope GmbH, Berlin, we can offer the development and production of pharmaceutical proteins and antibodies in human cell lines with optimised glycosylation pattern.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Czernyring 2269115 Heidelber
Telephone
Telephone
49 622 191 050
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250113621008/en

BUSINESSWIRE
13 Jan 2025

https://www.globenewswire.com/news-release/2024/07/03/2907929/0/en/Pentixapharm-Acquires-Target-Discovery-Business-of-Glycotope.html

GLOBENEWSWIRE
03 Jul 2024

https://www.globenewswire.com/news-release/2024/04/08/2858888/0/en/Glycotope-to-present-platform-approach-for-development-of-anti-GlycoTarget-antibodies-at-2024-AACR-Meeting.html

GLOBENEWSWIRE
08 Apr 2024

https://www.globenewswire.com//news-release/2023/12/11/2793550/0/en/Glycotope-and-Evotec-enter-licensing-agreement-to-combine-Glycotope-antibodies-and-Evotec-s-immune-cell-engager-platform.html

GLOBENEWSWIRE
11 Dec 2023

https://www.globenewswire.com//news-release/2023/11/03/2772992/0/en/Glycotope-Presents-anti-GlycoTarget-Antibodies-at-the-2023-Society-for-Immunotherapy-of-Cancer-SITC-Meeting.html

GLOBENEWSWIRE
03 Nov 2023

https://www.globenewswire.com//news-release/2023/10/16/2760297/0/en/LegoChem-Biosciences-Enters-Worldwide-Licensing-Agreement-with-Glycotope-for-Antibody-Drug-Conjugate-Development.html

GLOBENEWSWIRE
16 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty